Who Paid My Doc
PROTECT Study in IgA Nephropathy
Research payments
$311,764
Through program year 2025, $311,764 in research payments was reported against PROTECT Study in IgA Nephropathy, across 232 payments, paid by Retrophin, Inc..
- Paid by
- Retrophin, Inc.
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
1 row| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | Research | $311,764 | 232 |
Breakdown
Usually the institution or organisation running the study, not a person.
Only reported on some payments, and a payment can report more than one category, so these amounts overlap.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Isabelle Ayoub Columbus, OH Named on 36 payments
- Laura Kooienga Denver, CO Named on 20 payments
- Arnold Silva Meridian, ID Named on 19 payments
- Sreedhar Mandayam Houston, TX Named on 18 payments
- Siddhartha Kattamanchi Marshfield, WI Named on 17 payments
- Richard Lafayette Stanford, CA Named on 16 payments
- Dana Rizk Birmingham, AL Named on 15 payments
- Ellen McCarthy Kansas City, KS Named on 15 payments
- Dawn Caster Louisville, KY Named on 14 payments
- Abdallahsassine Geara Philadelphia, PA Named on 13 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.